✦ LIBER ✦

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

✍ Scribed by Zheng, Jin-Ping; Wen, Fu-Qiang; Bai, Chun-Xue; Wan, Huan-Ying; Kang, Jian; Chen, Ping; Yao, Wan-Zhen; Ma, Li-Jun; Li, Xia; Raiteri, Luca; Sardina, Marco; Gao, Yi; Wang, Bai-Song; Zhong, Nan-Shan

Book ID: 121810862
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 412 KB
Volume: 2
Category: Article
ISSN: 2213-2600
DOI: 10.1016/S2213-2600(13)70286-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Azithromycin maintenance treatment in pa

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial

✍ Uzun, Sevim (author);Djamin, Remco S. (author);Kluytmans, Jan A.J.W. (author);Mu 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 215 KB

Azithromycin maintenance treatment in pa

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial

✍ Uzun, Sevim (author);Djamin, Remco S. (author);Kluytmans, Jan A.J.W. (author);Mu 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 215 KB

Efficacy and safety of the p38 MAPK inhi

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

✍ Watz, Henrik; Barnacle, Helen; Hartley, Benjamin F; Chan, Robert 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 405 KB

Effects of N-acetylcysteine on outcomes

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

✍ Marc Decramer; Maureen Rutten-van Mölken; PN Richard Dekhuijzen; Thierry Trooste 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 115 KB

Effects of N-acetylcysteine on outcomes

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial: The Lancet 2005;365(9470):1552–60

✍ M. Decramer; M. Rutten-van Mölken; P.N.R. Dekhuijzen; T. Troosters; C. van Herwa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB